<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35935185</PMID><DateRevised><Year>2023</Year><Month>07</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-302X</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in microbiology</Title><ISOAbbreviation>Front Microbiol</ISOAbbreviation></Journal><ArticleTitle>Targeting Emerging RNA Viruses by Engineered Human Superantibody to Hepatitis C Virus RNA-Dependent RNA Polymerase.</ArticleTitle><Pagination><StartPage>926929</StartPage><MedlinePgn>926929</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">926929</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmicb.2022.926929</ELocationID><Abstract><AbstractText>RNA-dependent RNA polymerase (RdRp) is a unique and highly conserved enzyme across all members of the RNA virus superfamilies. Besides, humans do not have a homolog of this protein. Therefore, the RdRp is an attractive target for a broadly effective therapeutic agent against RNA viruses. In this study, a formerly generated cell-penetrating human single-chain antibody variable fragment (superantibody) to a conformational epitope of hepatitis C virus (HCV) RdRp, which inhibited the polymerase activity leading to the HCV replication inhibition and the host innate immunity restoration, was tested against emerging/reemerging RNA viruses. The superantibody could inhibit the replication of the other members of the <i>Flaviviridae</i> (DENV serotypes 1-4, ZIKV, and JEV), <i>Picornaviridae</i> (genus <i>Enterovirus</i>: EV71, CVA16), and <i>Coronaviridae</i> (genus <i>Alphacoronavirus</i>: PEDV, and genus <i>Betacoronavirus</i>: SARS-CoV-2 (Wuhan wild-type and the variants of concern), in a dose-dependent manner, as demonstrated by the reduction of intracellular viral RNAs and numbers of the released infectious particles. Computerized simulation indicated that the superantibody formed contact interfaces with many residues at the back of the thumb domain (thumb II site, T2) of DENV, ZIKV, JEV, EV71, and CVA16 and fingers and thumb domains of the HCV and coronaviruses (PEDV and SARS-CoV-2). The superantibody binding may cause allosteric change in the spatial conformation of the enzyme and disrupt the catalytic activity, leading to replication inhibition. Although the speculated molecular mechanism of the superantibody needs experimental support, existing data indicate that the superantibody has high potential as a non-chemical broadly effective anti-positive sense-RNA virus agent.</AbstractText><CopyrightInformation>Copyright © 2022 Glab-ampai, Kaewchim, Thavorasak, Saenlom, Thepsawat, Mahasongkram, Thueng-In, Sookrung, Chaicumpa and Chulanetra.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Glab-Ampai</LastName><ForeName>Kittirat</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Center of Research Excellence in Therapeutic Proteins and Antibody Engineering, Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaewchim</LastName><ForeName>Kanasap</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Center of Research Excellence in Therapeutic Proteins and Antibody Engineering, Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Immunology, Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thavorasak</LastName><ForeName>Techit</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Center of Research Excellence in Therapeutic Proteins and Antibody Engineering, Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Immunology, Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saenlom</LastName><ForeName>Thanatsaran</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Center of Research Excellence in Therapeutic Proteins and Antibody Engineering, Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thepsawat</LastName><ForeName>Watayagorn</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Center of Research Excellence in Therapeutic Proteins and Antibody Engineering, Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahasongkram</LastName><ForeName>Kodchakorn</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Center of Research Excellence in Therapeutic Proteins and Antibody Engineering, Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thueng-In</LastName><ForeName>Kanyarat</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>School of Pathology, Translational Medicine Program, Institute of Medicine, Suranaree University of Technology, Nakhon Ratchasima, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sookrung</LastName><ForeName>Nitat</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Center of Research Excellence in Therapeutic Proteins and Antibody Engineering, Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Research Incubator Unit, Department of Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaicumpa</LastName><ForeName>Wanpen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Center of Research Excellence in Therapeutic Proteins and Antibody Engineering, Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chulanetra</LastName><ForeName>Monrat</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center of Research Excellence in Therapeutic Proteins and Antibody Engineering, Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Microbiol</MedlineTA><NlmUniqueID>101548977</NlmUniqueID><ISSNLinking>1664-302X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">RNA viruses</Keyword><Keyword MajorTopicYN="N">RNA-dependent RNA polymerase</Keyword><Keyword MajorTopicYN="N">computerized simulation</Keyword><Keyword MajorTopicYN="N">focus-forming assay</Keyword><Keyword MajorTopicYN="N">human single-chain antibody variable fragment</Keyword><Keyword MajorTopicYN="N">phage display</Keyword><Keyword MajorTopicYN="N">plaque-forming assay</Keyword><Keyword MajorTopicYN="N">superantibody (cell penetrating antibody)</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>8</Day><Hour>3</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35935185</ArticleId><ArticleId IdType="pmc">PMC9355540</ArticleId><ArticleId IdType="doi">10.3389/fmicb.2022.926929</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abbass S., Kamal E., Salama M., Salman T., Sabry A., Abdel-Razek W. (2021). Efficacy and safety of sofosbuvir plus daclatasvir or ravidasvir in patients with COVID-19: a randomized controlled trial. J. Med. Virol. 93 6750–6759. 10.1002/jmv.27264</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27264</ArticleId><ArticleId IdType="pmc">PMC8426808</ArticleId><ArticleId IdType="pubmed">34379337</ArticleId></ArticleIdList></Reference><Reference><Citation>Agostini M. L., Andres E. L., Sims A. C., Graham R. L., Sheahan T. P., Lu X., et al. (2018). Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease. mBio 9 e00221–e00218. 10.1128/mBio.00221-18</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00221-18</ArticleId><ArticleId IdType="pmc">PMC5844999</ArticleId><ArticleId IdType="pubmed">29511076</ArticleId></ArticleIdList></Reference><Reference><Citation>Biswal B. K., Cherney M. M., Wang M., Chan L., Yannopoulos C. G., Bilimoria D. (2005). Crystal structures of the RNA-dependent RNA polymerase genotype 2a of hepatitis C virus reveal two conformations and suggest mechanisms of inhibition by non-nucleoside inhibitors. J. Biol. Chem. 280 18202–18210. 10.1074/jbc.M413410200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M413410200</ArticleId><ArticleId IdType="pubmed">15746101</ArticleId></ArticleIdList></Reference><Reference><Citation>Boumaza A., Gay L., Mezouar S., Bestion E., Diallo A. B., Michel M., et al. (2021). Monocytes and macrophages, targets of severe acute respiratory syndrome coronavirus 2: the clue for coronavirus disease 2019 immunoparalysis. J. Infect. Dis. 224, 395–406. 10.1093/infdis/jiab044</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab044</ArticleId><ArticleId IdType="pmc">PMC7928817</ArticleId><ArticleId IdType="pubmed">33493287</ArticleId></ArticleIdList></Reference><Reference><Citation>Bressanelli S., Tomei L., Roussel A., Incitti I., Vitale R. L., Mathieu M. (1999). Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus. Proc. Natl. Acad. Sci. U. S. A. 96 13034–13039. 10.1073/pnas.96.23.13034</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.96.23.13034</ArticleId><ArticleId IdType="pmc">PMC23895</ArticleId><ArticleId IdType="pubmed">10557268</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks N. A., Esparon S., Pouniotis D., Pietersz G. A. (2015). Comparative immunogenicity of a cytotoxic T cell epitope delivered by penetratin and TAT cell penetrating peptides. Molecules 20 14033–14050. 10.3390/molecules200814033</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules200814033</ArticleId><ArticleId IdType="pmc">PMC6332296</ArticleId><ArticleId IdType="pubmed">26247926</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks N. A., Pouniotis D. S., Tang C. K., Apostolopoulos V., Pietersz G. A. (2010). Cell-penetrating peptides: application in vaccine delivery. Biochim. Biophys. Acta 1805 25–34. 10.1016/j.bbcan.2009.09.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbcan.2009.09.004</ArticleId><ArticleId IdType="pubmed">19782720</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruenn J. A. (2003). A structural and primary sequence comparison of the viral RNA-dependent RNA polymerases. Nucleic Acids Res. 31 1821–1829. 10.1093/nar/gkg277</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkg277</ArticleId><ArticleId IdType="pmc">PMC152793</ArticleId><ArticleId IdType="pubmed">12654997</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan-Yeng M., Xu R. H., Shi Z. (2015). Bat origin of human coronaviruses. Virol. J. 12:21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4687304</ArticleId><ArticleId IdType="pubmed">26689940</ArticleId></ArticleIdList></Reference><Reference><Citation>Choy K. T., Wong A. Y., Kaewpreedee P., Sia S. F., Chen D., Hui K. P. Y. (2020). Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro. Antiviral Res. 178:104786. 10.1016/j.antiviral.2020.104786</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2020.104786</ArticleId><ArticleId IdType="pmc">PMC7127386</ArticleId><ArticleId IdType="pubmed">32251767</ArticleId></ArticleIdList></Reference><Reference><Citation>Coghlan A. (2022). Super Antibodies Break the Cell Barrier. London, UK: NewScientist.</Citation></Reference><Reference><Citation>De Clercq E. (2013). Antivirals: past, present and future. Biochem. Pharmacol. 85 727–744. 10.1016/j.bcp.2012.12.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2012.12.011</ArticleId><ArticleId IdType="pubmed">23270991</ArticleId></ArticleIdList></Reference><Reference><Citation>Derossi D., Joliot A. H., Chassaing G., Prochiantz A. (1994). The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 269 10444–10450.</Citation><ArticleIdList><ArticleId IdType="pubmed">8144628</ArticleId></ArticleIdList></Reference><Reference><Citation>European Centre for Disease Prevention and Control (2020). Dengue Worldwide Overview. Solna: European Centre for Disease Prevention and Control.</Citation></Reference><Reference><Citation>Frediansyah A., Nainu F., Dhama K., Mudatsir M., Harapan H. (2021). Remdesivir and its antiviral activity against COVID-19: a systematic review. Clin. Epidemiol. Glob. Health 9 123–127. 10.1016/j.cegh.2020.07.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cegh.2020.07.011</ArticleId><ArticleId IdType="pmc">PMC7410793</ArticleId><ArticleId IdType="pubmed">32838064</ArticleId></ArticleIdList></Reference><Reference><Citation>Glab-ampai K., Chulanetra M., Malik A. A., Juntadech T., Thanongsaksrikul J., Srimanote P. (2017). Human single chain-transbodies that bound to domain-I of non-structural protein 5A (NS5A) of hepatitis C virus. Sci. Rep. 7:15042. 10.1038/s41598-017-14886-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-14886-9</ArticleId><ArticleId IdType="pmc">PMC5678119</ArticleId><ArticleId IdType="pubmed">29118372</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong P., Peersen O. B. (2010). Structural basis for active site closure by the poliovirus RNA-dependent RNA polymerase. Proc. Natl. Acad. Sci. U. S. A. 107 22505–22510. 10.1073/pnas.1007626107</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1007626107</ArticleId><ArticleId IdType="pmc">PMC3012486</ArticleId><ArticleId IdType="pubmed">21148772</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorbalenya A. E., Pringle F. M., Zeddam J. L., Luke B. T., Cameron C. E., Kalmakoff J., et al. (2002). The palm subdomain-based active site is internally permuted in viral RNA-dependent RNA polymerases of an ancient lineage. J. Mol. Biol. 324 47–62. 10.1016/s0022-2836(02)01033-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-2836(02)01033-1</ArticleId><ArticleId IdType="pmc">PMC7127740</ArticleId><ArticleId IdType="pubmed">12421558</ArticleId></ArticleIdList></Reference><Reference><Citation>Honorato R. V., Koukos P. I., Jimenez-Garcia B., Tsaregorodtsev A., Verlato M., Giachetti A., et al. (2021). Structural biology in the clouds: the WeNMR-EOSC Ecosystem. Front. Mol. Biosci. 8:729513. 10.3389/fmolb.2021.729513</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2021.729513</ArticleId><ArticleId IdType="pmc">PMC8356364</ArticleId><ArticleId IdType="pubmed">34395534</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B., Ge X., Wang L. F., Shi Z. (2015). Bat origin of human coronaviruses. Virol. J. 12:221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4687304</ArticleId><ArticleId IdType="pubmed">26689940</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia H., Gong P. (2019). A structure-function diversity survey of the RNA-dependent RNA polymerases from the positive-strand RNA viruses. Front. Microbiol. 10:1945. 10.3389/fmicb.2019.01945</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2019.01945</ArticleId><ArticleId IdType="pmc">PMC6713929</ArticleId><ArticleId IdType="pubmed">31507560</ArticleId></ArticleIdList></Reference><Reference><Citation>Jumper J., Evans R., Pritzel A., Green T., Figurnov M., Ronneberger O., et al. (2021). Highly accurate protein structure prediction with AlphaFold. Nature 596 583–589. 10.1038/s41586-021-03819-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03819-2</ArticleId><ArticleId IdType="pmc">PMC8371605</ArticleId><ArticleId IdType="pubmed">34265844</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung K., Hu H., Saif L. J. (2016). Porcine deltacoronavirus infection: etiology, cell culture for virus isolation and propagation, molecular epidemiology and pathogenesis. Virus Res. 226 50–59. 10.1016/j.virusres.2016.04.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2016.04.009</ArticleId><ArticleId IdType="pmc">PMC7114557</ArticleId><ArticleId IdType="pubmed">27086031</ArticleId></ArticleIdList></Reference><Reference><Citation>Khandia R., Munjal A., Dhama K., Karthik K., Tiwari R., Malik Y. S., et al. (2018). Modulation of Dengue/Zika virus pathogenicity by antibody-dependent enhancement and strategies to protect against enhancement in Zika virus infection. Front. Immunol. 9:597. 10.3389/fimmu.2018.00597</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00597</ArticleId><ArticleId IdType="pmc">PMC5925603</ArticleId><ArticleId IdType="pubmed">29740424</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulkarni R. (2020). “Antibody-dependent enhancement of viral infections,” in Dynamics of Immune Activation in Viral Diseases, ed. Bramhachari P. V. (Singapore: Springer Singapore; ), 9–41.</Citation></Reference><Reference><Citation>Kulkeaw K., Sakolvaree Y., Srimanote P., Tongtawe P., Maneewatch S., Sookrung N. (2009). Human monoclonal ScFv neutralize lethal Thai cobra, Naja kaouthia, neurotoxin. J. Proteomics 72 270–282. 10.1016/j.jprot.2008.12.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jprot.2008.12.007</ArticleId><ArticleId IdType="pubmed">19162253</ArticleId></ArticleIdList></Reference><Reference><Citation>Kusakawa T., Shimakami T., Kaneko S., Yoshioka K., Murakami S. (2007). Functional interaction of hepatitis C virus NS5B with nucleolin GAR domain. J. Biochem. 141 917–927. 10.1093/jb/mvm102</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jb/mvm102</ArticleId><ArticleId IdType="pubmed">17569707</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyle J. L., Harris E. (2008). Global spread and persistence of dengue. Ann. Rev. Microbiol. 62 71–92.</Citation><ArticleIdList><ArticleId IdType="pubmed">18429680</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Pogam S., Kang H., Harris S. F., Leveque V., Giannetti A. M., Ali S., et al. (2006). Selection and characterization of replicon variants dually resistant to thumb- and palm-binding nonnucleoside polymerase inhibitors of the hepatitis C virus. J. Virol. 80 6146–6154. 10.1128/JVI.02628-05</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02628-05</ArticleId><ArticleId IdType="pmc">PMC1472602</ArticleId><ArticleId IdType="pubmed">16731953</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Johnson K. A. (2016). Thumb site 2 inhibitors of hepatitis C viral RNA-dependent RNA polymerase allosterically block the transition from initiation to elongation. J. Biol. Chem. 291, 10067–10077. 10.1074/jbc.M115.708354</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.708354</ArticleId><ArticleId IdType="pmc">PMC4858960</ArticleId><ArticleId IdType="pubmed">26851276</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim S. P., Noble C. G., She C. C., Soh T. S., El Sahili A., Chan G. K., et al. (2016). Potent allosteric dengue virus NS5 polymerase inhibitors: mechanism of action and resistance profiling. PLoS Pathog. 12:e1005737. 10.1371/journal.ppat.1005737</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005737</ArticleId><ArticleId IdType="pmc">PMC4976923</ArticleId><ArticleId IdType="pubmed">27500641</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Soh W. T., Kishikawa J. I., Hirose M., Nakayama E. E., Li S., et al. (2021). An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies. Cell 184 3452–3466.e18. 10.1016/j.cell.2021.05.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.05.032</ArticleId><ArticleId IdType="pmc">PMC8142859</ArticleId><ArticleId IdType="pubmed">34139176</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirdita M., Schütze K., Moriwaki Y., Heo L., Ovchinnikov S., Steinegger M. (2022). ColabFold: making protein folding accessible to all. Nat. Methods 19, 679–682. 10.1038/s41592-022-01488-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-022-01488-1</ArticleId><ArticleId IdType="pmc">PMC9184281</ArticleId><ArticleId IdType="pubmed">35637307</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayan R., Tripathi S. (2020). Intrinsic ADE: the dark side of antibody dependent enhancement during dengue infection. Front. Cell. Infect. Microbiol. 10:580096. 10.3389/fcimb.2020.580096</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.580096</ArticleId><ArticleId IdType="pmc">PMC7573563</ArticleId><ArticleId IdType="pubmed">33123500</ArticleId></ArticleIdList></Reference><Reference><Citation>Noobrakhsh F., Abdolmohammadi K., Fatahi Y., Dalili H., Rasoolinejad M., Rezaei F., et al. (2019). Zika virus infection, basic and clinical aspects: a review article. Iran. J. Public Health 48 20–31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6401583</ArticleId><ArticleId IdType="pubmed">30847308</ArticleId></ArticleIdList></Reference><Reference><Citation>Novel Influenza A/H1N1 Investigation Team (2009). Description of the early stage of pandemic (H1N1) 2009 in Germany, 27 April-16 June 2009. Euro. Surveill. 14:19295. 10.2807/ese.14.31.19295-en</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/ese.14.31.19295-en</ArticleId><ArticleId IdType="pubmed">19660249</ArticleId></ArticleIdList></Reference><Reference><Citation>Payne S. (2017). “Chapter 10—Introduction to RNA viruses,” in Viruses, ed. Payne S. (Cambridge, MA: Academic Press; ), 97–105.</Citation></Reference><Reference><Citation>Pensaert M. B., de Bouck P. (1978). A new coronavirus-like particle associated with diarrhea in swine. Arch. Virol. 58 243–247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7086830</ArticleId><ArticleId IdType="pubmed">83132</ArticleId></ArticleIdList></Reference><Reference><Citation>Phanthong S., Densumite J., Seesuay W., Thanongsaksrikul J., Teimoori S., Sookrung N., et al. (2020). Human antibodies to VP4 inhibit replication of enteroviruses across subgenotypes and serotypes and enhance host innate immunity. Front. Microbiol. 11:562768. 10.3389/fmicb.2020.562768</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.562768</ArticleId><ArticleId IdType="pmc">PMC7545151</ArticleId><ArticleId IdType="pubmed">33101238</ArticleId></ArticleIdList></Reference><Reference><Citation>Picarazzi F., Vicenti I., Saladini F., Zazzi M., Mori M. (2020). Targeting the RdRp of emerging RNA viruses: the structure-based drug design challenge. Molecules 25:5695. 10.3390/molecules25235695</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25235695</ArticleId><ArticleId IdType="pmc">PMC7730706</ArticleId><ArticleId IdType="pubmed">33287144</ArticleId></ArticleIdList></Reference><Reference><Citation>Poch O., Sauvaget I., Delarue M., Tordo N. (1989). Identification of four conserved motifs among the RNA-dependent polymerase encoding elements. EMBO J. 8 3867–74. 10.1002/j.1460-2075.1989.tb08565.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1460-2075.1989.tb08565.x</ArticleId><ArticleId IdType="pmc">PMC402075</ArticleId><ArticleId IdType="pubmed">2555175</ArticleId></ArticleIdList></Reference><Reference><Citation>Poungpair O., Pootong A., Maneewatch S., Srimanote P., Tongtawe P., Songserm T., et al. (2010). A human single chain transbody specific to matrix protein (M1) interferes with the replication of influenza A virus. Bioconjug. Chem. 21 1134–1141. 10.1021/bc900251u</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bc900251u</ArticleId><ArticleId IdType="pubmed">20560610</ArticleId></ArticleIdList></Reference><Reference><Citation>Sánchez-Zuno G. A., Matuz-Flores M. G., González-Estevez G., Nicoletti F., Turrubiates-Hernández F. J., Mangano K., et al. (2021). A review: antibody-dependent enhancement in COVID-19: the not so friendly side of antibodies. Int. J. Immunopathol. Pharmacol. 35:20587384211050199. 10.1177/20587384211050199</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20587384211050199</ArticleId><ArticleId IdType="pmc">PMC8512237</ArticleId><ArticleId IdType="pubmed">34632844</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt N. J., Lennette E. H., Ho H. H. (1974). An apparently new enterovirus isolated from patients with disease of the central nervous system. J. Infect. Dis. 129 304–309.</Citation><ArticleIdList><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheahan T. P., Sims A. C., Graham R. L., Menachery V. D., Gralinski L. E., Case J. B., et al. (2017). Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Sci. Transl. Med. 9:eaal3653. 10.1126/scitranslmed.aal3653</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aal3653</ArticleId><ArticleId IdType="pmc">PMC5567817</ArticleId><ArticleId IdType="pubmed">28659436</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheahan T. P., Sims A. C., Zhou S., Graham R. L., Pruijssers A. J., Agostini M. L., et al. (2020). An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. Sci. Transl. Med. 2:eabb5883. 10.1126/scitranslmed.abb5883</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abb5883</ArticleId><ArticleId IdType="pmc">PMC7164393</ArticleId><ArticleId IdType="pubmed">32253226</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimakami T., Honda M., Kusakawa T., Murata T., Shimotohno K., Kaneko S., et al. (2006). Effect of hepatitis C virus (HCV) NS5B-nucleolin interaction on HCV replication with HCV subgenomic replicon. J. Virol. 80 3332–3340. 10.1128/JVI.80.7.3332-3340.2006</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.80.7.3332-3340.2006</ArticleId><ArticleId IdType="pmc">PMC1440399</ArticleId><ArticleId IdType="pubmed">16537600</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang X., Tian G., Zhao J., Zhou K. Y. (1998). Isolation and characterization of prevalent strains of avian influenza viruses in China. Chin. J. Anim. Poult. Infect. Dis. 20 1–5.</Citation></Reference><Reference><Citation>te Velthuis A. J. (2014). Common and unique features of viral RNA-dependent polymerases. Cell. Mol. Life. Sci. 71, 4403–4420. 10.1007/s00018-014-1695-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-014-1695-z</ArticleId><ArticleId IdType="pmc">PMC4207942</ArticleId><ArticleId IdType="pubmed">25080879</ArticleId></ArticleIdList></Reference><Reference><Citation>Thavorasak T., Chulanetra M., Glab-ampai K., Teeranitayatarn K., Songserm T., Yodsheewan R. (2022). Novel neutralizing epitope of PEDV S1 protein identified by IgM monoclonal antibody. Viruses 14:125. 10.3390/v14010125</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14010125</ArticleId><ArticleId IdType="pmc">PMC8778753</ArticleId><ArticleId IdType="pubmed">35062329</ArticleId></ArticleIdList></Reference><Reference><Citation>Thueng-In K., Thanongsaksrikul J., Jittavisutthikul S., Seesuay W., Chulanetra M., Sakolvaree Y., et al. (2014). Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase. mAbs 6 1327–1339. 10.4161/mabs.29978</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/mabs.29978</ArticleId><ArticleId IdType="pmc">PMC4622650</ArticleId><ArticleId IdType="pubmed">25517317</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian L., Qiang T., Liang C., Ren X., Jia M., Zhang J., et al. (2021). RNA-dependent RNA polymerase (RdRp) inhibitors: the current landscape and repurposing for the COVID-19 pandemic. Eur. J. Med. Chem. 213:113201. 10.1016/j.ejmech.2021.113201</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2021.113201</ArticleId><ArticleId IdType="pmc">PMC7826122</ArticleId><ArticleId IdType="pubmed">33524687</ArticleId></ArticleIdList></Reference><Reference><Citation>van Zundert G. C. P., Rodrigues J. P. G. L. M., Trellet M., Schmitz C., Kastritis P. L., Karaca E., et al. (2016). The HADDOCK2.2 Web Server: user-friendly integrative modeling of biomolecular complexes. J. Mol. Biol. 428 720–725. 10.1016/j.jmb.2015.09.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2015.09.014</ArticleId><ArticleId IdType="pubmed">26410586</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkataraman S., Prasad B. V. L. S., Selvarajan R. (2018). RNA dependent RNA polymerases: insights from structure, function and evolution. Viruses 10:76. 10.3390/v10020076</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v10020076</ArticleId><ArticleId IdType="pmc">PMC5850383</ArticleId><ArticleId IdType="pubmed">29439438</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z. (2005). Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11 791–796. 10.1038/nm1268</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1268</ArticleId><ArticleId IdType="pmc">PMC2918402</ArticleId><ArticleId IdType="pubmed">15951748</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallin R. F. (1998). A Practical Guide to ISO 109903-5: Cytotoxicity. Medical Devices and Diagnostic Industry. Available online at: https://www.mddionline.com/testing/practical-guide-iso-10993-5-cytotoxicity
(accessed July 9, 2021).</Citation></Reference><Reference><Citation>Wang M., Cao R., Zhang L., Yang X., Liu J., Xu M. (2020). Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 30 269–271. 10.1038/s41422-020-0282-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-020-0282-0</ArticleId><ArticleId IdType="pmc">PMC7054408</ArticleId><ArticleId IdType="pubmed">32020029</ArticleId></ArticleIdList></Reference><Reference><Citation>Winarski K. L., Tang J., Klenow L., Lee J., Coyle E. M., Manischewitz J. (2019). Antibody-dependent enhancement of influenza disease promoted by increase in hemagglutinin stem flexibility and virus fusion kinetics. Proc. Natl. Acad. Sci. U. S. A. 116 15194–15199. 10.1073/pnas.1821317116</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1821317116</ArticleId><ArticleId IdType="pmc">PMC6660725</ArticleId><ArticleId IdType="pubmed">31296560</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization [WHO] (2004). The 4th Edition of the Manual for the Virological Investigation of Polio. Geneva: WHO.</Citation></Reference><Reference><Citation>World Health Organization [WHO] (2019). Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Geneva: WHO.</Citation></Reference><Reference><Citation>World Health Organization Ebola Response Team (2014). Ebola virus disease in West Africa – the first 9 months of the epidemic and forward projections. N. Engl. J. Med. 371 1481–1495. 10.1056/NEJMoa1411100</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1411100</ArticleId><ArticleId IdType="pmc">PMC4235004</ArticleId><ArticleId IdType="pubmed">25244186</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J., Liu W., Gong P. (2015). A structural overview of RNA-dependent RNA polymerases from the Flaviviridae family. Int. J. Mol. Sci. 16 12943–12957. 10.3390/ijms160612943</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms160612943</ArticleId><ArticleId IdType="pmc">PMC4490480</ArticleId><ArticleId IdType="pubmed">26062131</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J., Luo Y., Shibu M. A., Toth I., Skwarczynskia M. (2019). Cell-penetrating peptides: efficient vectors for vaccine delivery. Curr. Drug. Deliv. 16 430–443. 10.2174/1567201816666190123120915</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1567201816666190123120915</ArticleId><ArticleId IdType="pmc">PMC6637094</ArticleId><ArticleId IdType="pubmed">30760185</ArticleId></ArticleIdList></Reference><Reference><Citation>Yap T. L., Xu T., Chen Y. L., Malet H., Egloff M. P., Canard B., et al. (2007). Crystal structure of the dengue virus RNA-dependent RNA polymerase catalytic domain at 1.85-angstrom resolution. J. Virol. 81 4753–4765. 10.1128/JVI.02283-06</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02283-06</ArticleId><ArticleId IdType="pmc">PMC1900186</ArticleId><ArticleId IdType="pubmed">17301146</ArticleId></ArticleIdList></Reference><Reference><Citation>Zein A. F. M. Z., Sulistiyana C. S., Raffaello W. M., Wibowo A., Pranata R. (2021). Sofosbuvir with daclatasvir and the outcomes of patients with COVID-19: a systematic review and meta-analysis with GRADE assessment. Postgrad. Med. J. 21 1–6. 10.1136/postgradmedj-2021-140287</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/postgradmedj-2021-140287</ArticleId><ArticleId IdType="pubmed">37066509</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>